Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma

By Mir Olivier   Ropert Stanislas   Babinet Antoine   Alexandre Jérôme   Larousserie Frédérique   Durand Jean-Philippe   Enkaoua Eric   Anract Philippe   Goldwasser François  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1059-1063

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis

By Rask Charlotte   Albertioni Freidoun   Bentzen Soeren M.   Schroeder Henrik   Peterson Curt  

Acta Oncologica, Vol. 37, Iss. 3, 1998-07 ,pp. : 277-284

Informa Healthcare

Access to resources Recommend Favorite

High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study

By Tedeschi Alessandra   Montillo Marco   Strocchi Elena   Cafro Anna   Tresoldi Elisabetta   Intropido Liliana   Nichelatti Michele   Marbello Laura   Baratè Claudia   Camaggi Carlo   Morra Enrica  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 771-779

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan

By Kudawara Ikuo  

Journal of Chemotherapy, Vol. 25, Iss. 1, 2013-02 ,pp. : 41-48

Maney Publishing

Access to resources Recommend Favorite

Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance

By  

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 52-61

John Wiley & Sons Inc

Access to resources Recommend Favorite